A Case of Severe Autoimmune Hemolytic Anemia After Receipt of First Dose of SARS-CoV-2 Vaccine

    July 2021 in “ International journal of laboratory hematology ”
    Tomas M Murdych
    TLDR An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.
    An 84-year-old man developed severe autoimmune hemolytic anemia (AIHA) three weeks after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine, presenting with dizziness, shortness of breath, and dark urine due to a significant drop in hemoglobin levels. His condition stabilized with corticosteroids and blood transfusions. This is the first reported case of AIHA following COVID-19 vaccination, suggesting a potential, though unproven, link and highlighting the need for clinicians to monitor for similar cases.
    Discuss this study in the Community →